Search

Search Constraints

You searched for: Author/Creator Rubbert-Roth, Andrea Subject Rheumatism -- Periodicals

Search Results

2. A randomised phase IIb study of mavrilimumab, a novel GM–CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis. Issue 6 (17th February 2017)

3. A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study). Issue 1 (31st July 2013)

4. AB0277 EFFECT OF DISEASE DURATION AND OTHER PATIENT BASELINE CHARACTERISTICS ON OUTCOMES IN TOCILIZUMAB-TREATED RHEUMATOID ARTHRITIS PATIENTS: A POOLED ANALYSIS. (June 2019)

5. AB0610 PERSISTENT INFLAMMATION DESPITE TOCILIZUMAB TREATMENT IN 2 PATIENTS WITH LARGE VESSEL VASCULITIS AND AORTIC INVOLVEMENT REQUIRING AORTIC VALVE REPLACEMENT. (June 2019)

7. Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis. (29th January 2021)

8. Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. Issue 8 (13th May 2020)

10. Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy. (17th May 2022)